Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.39 |
| ▸ | MEN1 | O00255 | 5/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | PNMT | P11086 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL810324 | 0.82 | ALDH1A1 (0.45) | GABRA1GABRB2ALDH1A1PNMT | |
| SCHEMBL1486004 | 0.80 | ALDH1A1 (0.43) | GABRA1GABRB2ALDH1A1LMNAPNMT | |
| SCHEMBL16953041 | 0.80 | ALDH1A1 (0.43) | GABRA1GABRB2ALDH1A1PNMT | |
| SCHEMBL248573 | 0.79 | PNMT (0.56) | GABRA1GABRB2ALDH1A1AKR1B1MAPT | |
| SCHEMBL30679 | 0.79 | GABRA1 (0.47) | GABRA1GABRB2ALDH1A1AKR1B1KMT2A | |
| SCHEMBL16960550 | 0.78 | ALDH1A1 (0.59) | ALDH1A1KMT2AMEN1LMNAL3MBTL1 | |
| SCHEMBL7219053 | 0.78 | GABRA1 (0.47) | GABRA1GABRB2ALDH1A1AKR1B1KMT2A | |
| SCHEMBL1123438 | 0.78 | GABRA1 (0.47) | GABRA1GABRB2ALDH1A1AKR1B1KMT2A | |
| SCHEMBL16957146 | 0.77 | ALDH1A1 (0.41) | ALDH1A1MAPTKDM4EHSD17B10PNMT | |
| Methane SCHEMBL28621463 | 0.77 | GABRA1 (0.45) | GABRA1GABRB2ALDH1A1AKR1B1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6353070-B1 | STAR POLYMER OBTAINED BY POLYMERIZING VINYLAROMATIC MONOMER AND BRANCHING MONOMER CONTAINING AT LEAST TWO VINYLAROMATIC RADICALS IN PRESENCE OF CATALYST COMPRISING TRANSITION METAL COMPLEX, CATION-FORMING AGENT, OPTIONAL ALUMINUM COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-05 | — | — | US | disclosed |
| US-6303806-B2 | TITANIUM COMPOUNDS AS BRANCHING MONOMER UNITS | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-16 | — | — | US | disclosed |
| US-20010009966-A1 | Star polymers, and their preparation | WUNSCH JOSEF (DE) | 2001-07-26 | — | — | US | disclosed |
| US-6235838-B1 | USING STYRENE/DIPHENYLETHYLENE-DIENE BLOCK COPOLYMERS AS DISPERSING AUXILIARIES. | BASF AKTIENGESELLSCHAFT (DE) | 2001-05-22 | — | — | US | disclosed |
| US-4049596-A | Corrosion resistant aqueous and solvent-based primer compositions containing synergistic blends of zinc borate and barium metaborate pigments | PPG INDUSTRIES, INC. (US) | 1977-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010009966-A1 | Star polymers, and their preparation | MYB, PICALM, VMA21 | GABRA1 1158/4885GABRB2 2289/4885ALDH1A1 4099/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.